Viola Chen is a strategic advisor in the alternative protein sector, with a focus on fermentation and cultivated proteins. She brings deep expertise in Asian markets, supporting companies on commercialization, scaling, and go-to-market strategies for food innovation. Viola is a frequent conference speaker, and her perspectives have been featured in global media, including Bloomberg.
GLP-1 drugs are sweeping the globe, reshaping the weight management landscape.
Yet as questions around efficacy, side effects, cost, and accessibility emerge, growing attention is shifting to the “post-GLP-1 era.” Diverse approaches—ranging from nutritional interventions and functional foods to metabolic health formulations—are entering the field.
What structural changes has the GLP-1 boom already triggered? And as the market normalizes or cools, where will the next wave of innovation and business opportunities in weight management arise? Where are the advantages and opportunities for enterprises?